Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enno Schmidt

Showing results (141-150 of 348) with videos related to

Pageof 35
Sort By:
Biomolecules|February 27, 2026
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous PemphigoidShirin Emtenani, Tina Rastegar Lari, Charlotte Kiehne, et al.
Journal of the American Academy of Dermatology|June 22, 2002
Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoidEnno Schmidt, Cassian Sitaru, Barbara Schubert, et al.
Journal of the American Academy of Dermatology|December 2, 2014
Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case seriesMichael Kasperkiewicz, Franziska Schulze, Markus Meier, et al.
Frontiers in Medicine|October 5, 2020
Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous PemphigoidStanislav Khil'chenko, Katharina Boch, Nina van Beek, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 17, 2025
Pemphigus Is not Associated with an Increased Risk of Psychiatric Disorders during the Course of the DiseaseShirin Emtenani, Salam Alfarsi, Philip Curman, et al.
Ocular Immunology and Inflammation|September 6, 2024
The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific AutoantigenDharm Sodha, Sabrina Patzelt, Ali R Djalilian, et al.
The British Journal of Dermatology|May 27, 2024
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroidsKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
JAMA Dermatology|March 21, 2019
Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid With Concomitant Anti-Contactin-1-Positive Inflammatory Polyneuropathy Treated With Intravenous Immunoglobulins as a Manifestation of Epitope SpreadingAlexander Wald, Enno Schmidt, Ferdinand Toberer, et al.
Acta Dermato-Venereologica|March 21, 2022
Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus VulgarisKatharina Boch, Ewan A Langan, Enno Schmidt, et al.
Journal of the American Academy of Dermatology|November 9, 2024
COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individualsPhilip Curman, Khalaf Kridin, Henner Zirpel, et al.
Pageof 35

Showing results (141-150 of 348) with videos related to

Sort By:
Pageof 35
Biomolecules|February 27, 2026
Selective Complement Inhibition in Anti-p200 Pemphigoid: Immune Infiltrate Profiles and Therapeutic Implications Compared to Bullous PemphigoidShirin Emtenani, Tina Rastegar Lari, Charlotte Kiehne, et al.
Journal of the American Academy of Dermatology|June 22, 2002
Subacute prurigo variant of bullous pemphigoid: autoantibodies show the same specificity compared with classic bullous pemphigoidEnno Schmidt, Cassian Sitaru, Barbara Schubert, et al.
Journal of the American Academy of Dermatology|December 2, 2014
Treatment of bullous pemphigoid with adjuvant immunoadsorption: a case seriesMichael Kasperkiewicz, Franziska Schulze, Markus Meier, et al.
Frontiers in Medicine|October 5, 2020
Alterations of Total Serum Immunoglobulin Concentrations in Pemphigus and Pemphigoid: Selected IgG2 Deficiency in Bullous PemphigoidStanislav Khil'chenko, Katharina Boch, Nina van Beek, et al.
JID Innovations : Skin Science From Molecules to Population Health|December 17, 2025
Pemphigus Is not Associated with an Increased Risk of Psychiatric Disorders during the Course of the DiseaseShirin Emtenani, Salam Alfarsi, Philip Curman, et al.
Ocular Immunology and Inflammation|September 6, 2024
The Role of Serology in the Diagnosis of Ocular Predominant Mucous Membrane Pemphigoid and the Search for an Ocular-Specific AutoantigenDharm Sodha, Sabrina Patzelt, Ali R Djalilian, et al.
The British Journal of Dermatology|May 27, 2024
Risk of death, major adverse cardiac events and relapse in patients with bullous pemphigoid treated with systemic or topical corticosteroidsKhalaf Kridin, Katja Bieber, Artem Vorobyev, et al.
JAMA Dermatology|March 21, 2019
Overlap of Bullous, Anti-Laminin-332, and Anti-p200 Pemphigoid With Concomitant Anti-Contactin-1-Positive Inflammatory Polyneuropathy Treated With Intravenous Immunoglobulins as a Manifestation of Epitope SpreadingAlexander Wald, Enno Schmidt, Ferdinand Toberer, et al.
Acta Dermato-Venereologica|March 21, 2022
Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus VulgarisKatharina Boch, Ewan A Langan, Enno Schmidt, et al.
Journal of the American Academy of Dermatology|November 9, 2024
COVID-19 infection is associated with an elevated risk for autoimmune blistering diseases while COVID-19 vaccination decreases the risk: A large-scale population-based cohort study of 112 million individualsPhilip Curman, Khalaf Kridin, Henner Zirpel, et al.
Pageof 35